Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study.

Delanoy, Nicolas; Robbrecht, Debbie; Eisenberger, Mario; Sartor, Oliver; de Wit, Ronald; Mercier, Florence; Geffriaud-Ricouard, Christine; de Bono, Johann; Oudard, Stéphane

Delanoy, Nicolas; Robbrecht, Debbie; Eisenberger, Mario; Sartor, Oliver; de Wit, Ronald; Mercier, Florence; Geffriaud-Ricouard, Christine; de Bono, Johann; Oudard, Stéphane.

Afiliação

Delanoy N; Medical Oncology, Université de Paris, 75015 Paris, France.
Robbrecht D; Medical Oncology, AP-HP Paris, Centre, Georges Pompidou European Hospital, 75015 Paris, France.
Eisenberger M; Medical Oncology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Sartor O; Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21231, USA.
de Wit R; Medicine and Urology, Tulane Cancer Center, New Orleans, LA 70112, USA.
Mercier F; Medical Oncology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Geffriaud-Ricouard C; Stat Process, Boulevard de Sébastopol, 75003 Paris, France.
de Bono J; Sanofi, Europe Medical Oncology, 75008 Paris, France.
Oudard S; The Institute of Cancer Research, London SM2 5NG, UK.

Cancers (Basel) ; 13(6)2021 Mar 13.

Article em En | MEDLINE | ID: mdl-33805793

Palavras-chave

cabazitaxel; chemotherapy; clinical progression; metastatic castration-resistant prostate cancer; pain; taxanes; type of progression

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google